Swiss Registry for Neuromuscular Disorders
Swiss Registry for Neuromuscular Disorders (Swiss-Reg-NMD)
University of Bern
2,000 participants
Jun 20, 2018
OBSERVATIONAL
Conditions
Summary
The Swiss Patient Registry for DMD/BMD and SMA was launched in 2008 in order to give Swiss patients access to new therapies. It was founded with the financial support of several patient organizations and research foundations. Since 2008, children, adolescents and adults with DMD, BMD and SMA are registered with the help of all major muscle centers in Switzerland. After nearly ten years of activity, the Swiss Patient Registry for DMD/BMD and SMA implemented several adaptations in 2018 to meet current and future expectations of patient's organizations, health authorities and research organizations.
Eligibility
Inclusion Criteria3
- Children, adolescents and adults diagnosed with a NMD
- Who are living or treated for a NMD in Switzerland, and
- Who gave informed consent
Exclusion Criteria1
- None if diagnosis is confirmed, whenever possible, by genetic testing, or at least by biopsy and/or electroneuromyography, according to international standards for the diagnosis of the given NMD.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(19)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05102916